A double‐blind, placebo‐controlled, randomised, clinical study on the effectiveness of collagen peptide on osteoarthritis
Recent studies show that enzymatically hydrolysed collagen, the collagen peptide, is absorbed and distributed to joint tissues and has analgesic and anti‐inflammatory properties. A double‐blind, placebo‐controlled, randomised trial with collagen peptides isolated from pork skin (PCP) and bovine bone (BCP) sources was carried out to study the effectiveness of orally supplemented collagen peptide to control the progression of osteoarthritis in patients diagnosed with knee osteoarthritis. Improvement in treatment was assessed with reduction in Western Ontario McMaster Universities (WOMAC), visual analogue scale (VAS) and quality of life (QOL) scores from baseline to 13 weeks (Visit 7). Safety and tolerability were also evaluated.
Original Article Source Credits: Wiley Online Library , https://onlinelibrary.wiley.com/
Article Written By: Suresh Kumar , Fumihito Sugihara, Keiji Suzuki, Naoki Inoue and Sriraam Venkateswarathirukumara
Original Article Posted on: 22 May 2014
Link to Original Article: https://onlinelibrary.wiley.com/doi/abs/10.1002/jsfa.6752